Synovus Financial’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.32M | Buy |
45,358
+6,330
| +16% | +$582K | 0.05% | 224 |
|
|
2025
Q2 | $3.4M | Sell |
39,028
-3,183
| -8% | -$270K | 0.04% | 255 |
|
|
2025
Q1 | $3.79M | Sell |
42,211
-18,708
| -31% | -$1.67M | 0.05% | 221 |
|
|
2024
Q4 | $4.87M | Sell |
60,919
-5,819
| -9% | -$504K | 0.06% | 184 |
|
|
2024
Q3 | $6.01M | Buy |
66,738
+783
| +1% | +$65.9K | 0.07% | 178 |
|
|
2024
Q2 | $5.19M | Sell |
65,955
-33,024
| -33% | -$2.71M | 0.07% | 181 |
|
|
2024
Q1 | $8.63M | Sell |
98,979
-1,343
| -1% | -$115K | 0.11% | 114 |
|
|
2023
Q4 | $8.27M | Sell |
100,322
-5,422
| -5% | -$413K | 0.12% | 111 |
|
|
2023
Q3 | $8.29M | Buy |
105,744
+4,091
| +4% | +$342K | 0.09% | 135 |
|
|
2023
Q2 | $8.96M | Sell |
101,653
-877
| -0.9% | -$75.5K | 0.1% | 134 |
|
|
2023
Q1 | $8.27M | Buy |
102,530
+2,338
| +2% | +$191K | 0.09% | 134 |
|
|
2022
Q4 | $7.79M | Buy |
100,192
+435
| +0.4% | +$35.3K | 0.09% | 140 |
|
|
2022
Q3 | $8.05M | Buy |
99,757
+3,949
| +4% | +$355K | 0.1% | 127 |
|
|
2022
Q2 | $8.6M | Buy |
95,808
+350
| +0.4% | +$35.5K | 0.1% | 129 |
|
|
2022
Q1 | $10.6M | Buy |
95,458
+5,328
| +6% | +$563K | 0.11% | 120 |
|
|
2021
Q4 | $9.32M | Buy |
90,130
+4,353
| +5% | +$504K | 0.09% | 136 |
|
|
2021
Q3 | $10.8M | Buy |
85,777
+27,003
| +46% | +$3.5M | 0.11% | 120 |
|
|
2021
Q2 | $7.3M | Buy |
58,774
+6,800
| +13% | +$854K | 0.07% | 148 |
|
|
2021
Q1 | $6.13M | Buy |
51,974
+19,512
| +60% | +$2.29M | 0.07% | 148 |
|
|
2020
Q4 | $3.81M | Buy |
32,462
+5,241
| +19% | +$577K | 0.04% | 198 |
|
|
2020
Q3 | $2.83M | Sell |
27,221
-7,535
| -22% | -$757K | 0.04% | 216 |
|
|
2020
Q2 | $3.19M | Sell |
34,756
-13,604
| -28% | -$1.3M | 0.05% | 181 |
|
|
2020
Q1 | $4.36M | Buy |
48,360
+14,037
| +41% | +$1.49M | 0.06% | 163 |
|
|
2019
Q4 | $3.89M | Sell |
34,323
-453
| -1% | -$49.7K | 0.05% | 166 |
|
|
2019
Q3 | $3.78M | Buy |
34,776
+4,149
| +14% | +$433K | 0.06% | 156 |
|
|
2019
Q2 | $2.98M | Buy |
30,627
+1,510
| +5% | +$138K | 0.04% | 180 |
|
|
2019
Q1 | $2.64M | Buy |
29,117
+855
| +3% | +$76.5K | 0.04% | 191 |
|
|
2018
Q4 | $2.56M | Buy |
28,262
+3,627
| +15% | +$339K | 0.05% | 185 |
|
|
2018
Q3 | $2.42M | Buy |
24,635
+8,878
| +56% | +$821K | 0.04% | 204 |
|
|
2018
Q2 | $1.35M | Buy |
15,757
+469
| +3% | +$39.2K | 0.02% | 269 |
|
|
2018
Q1 | $1.22M | Buy |
15,288
+532
| +4% | +$43.9K | 0.02% | 287 |
|
|
2017
Q4 | $1.19M | Sell |
14,756
-198
| -1% | -$15.9K | 0.02% | 279 |
|
|
2017
Q3 | $1.16M | Sell |
14,954
-17,468
| -54% | -$1.45M | 0.02% | 266 |
|
|
2017
Q2 | $2.88M | Buy |
32,422
+4,679
| +17% | +$395K | 0.06% | 156 |
|
|
2017
Q1 | $2.24M | Buy |
27,743
+2,435
| +10% | +$190K | 0.05% | 168 |
|
|
2016
Q4 | $1.8M | Buy |
25,308
+475
| +2% | +$37.3K | 0.04% | 180 |
|
|
2016
Q3 | $2.15M | Buy |
24,833
+14,145
| +132% | +$1.23M | 0.05% | 155 |
|
|
2016
Q2 | $927K | Buy |
10,688
+349
| +3% | +$28.2K | 0.02% | 271 |
|
|
2016
Q1 | $776K | Buy |
10,339
+444
| +4% | +$33.4K | 0.02% | 284 |
|
|
2015
Q4 | $763K | Buy |
9,895
+4,944
| +100% | +$372K | 0.02% | 291 |
|
|
2015
Q3 | $331K | Buy |
4,951
+1,418
| +40% | +$104K | 0.01% | 377 |
|
|
2015
Q2 | $263K | Buy |
3,533
+432
| +14% | +$33K | 0.01% | 402 |
|
|
2015
Q1 | $240K | Buy |
3,101
+354
| +13% | +$26.8K | 0.01% | 431 |
|
|
2014
Q4 | $197K | Buy |
2,747
+30
| +1% | +$2.08K | 0.01% | 447 |
|
|
2014
Q3 | $167K | Buy |
2,717
+1,097
| +68% | +$69.7K | ﹤0.01% | 446 |
|
|
2014
Q2 | $103K | Buy |
1,620
+489
| +43% | +$29.7K | ﹤0.01% | 481 |
|
|
2014
Q1 | $68K | Hold |
1,131
| – | – | ﹤0.01% | 534 |
|
|
2013
Q4 | $65K | Buy |
1,131
+155
| +16% | +$8.79K | ﹤0.01% | 507 |
|
|
2013
Q3 | $52K | Sell |
976
-36,535
| -97% | -$1.97M | ﹤0.01% | 520 |
|
|
2013
Q2 | $1.93M | Buy |
+37,511
| New | +$1.85M | 0.06% | 175 |
|
Other funds holding MDT
Synovus Financial's MDT Position: Q3 2025 in Review
Synovus Financial increased its Medtronic (MDT) stake by 16% in Q3 2025, buying an estimated $582K and bringing the position to 45,358 shares worth $4.32M. The position accounts for 0.05% of the portfolio, ranked #224.
Synovus Financial first reported a position in MDT in Q2 2013 and has held it in 50 quarters since. The position peaked at $10.8M in Q3 2021. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Synovus Financial held 45,358 shares of Medtronic worth $4.32M as of Q3 2025.
- Synovus Financial bought 6,330 Medtronic shares in Q3 2025, an estimated $582K.
- Medtronic made up 0.05% of Synovus Financial's portfolio in Q3 2025, its #224 holding.
- Synovus Financial first reported a position in Medtronic in Q2 2013 and has held it in 50 quarters since.
- Synovus Financial's Medtronic position peaked at $10.8M in Q3 2021.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.